Fertility preservation in women (Q38156039)

29 August 2017

Fertility preservation in women (English)

1 reference

29 August 2017

Marie-Madeleine Dolmans

series ordinal

2

object named as

Marie-Madeleine Dolmans

0 references

Jacques Donnez

series ordinal

1

object named as

Jacques Donnez

1 reference

29 August 2017

Marie-Madeleine Dolmans

series ordinal

2

1 reference

29 August 2017

29 October 2013

1 reference

Nature Reviews Endocrinology

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

735-749

1 reference

29 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.205

29 August 2017

0 references

cites work

Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Current approach to fertility preservation by embryo cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue cryopreservation and transplantation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue cryopreservation and transplantation in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation for young patients with cancer: who is at risk and what can be offered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The effects of radiotherapy and chemotherapy on female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

How does bone marrow transplantation affect ovarian function and fertility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Predicting age of ovarian failure after radiation to a field that includes the ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The radiosensitivity of the human oocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Preservation of fertility in females with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Human ovarian reserve from conception to the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation medicine: options for young adults and children with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian cryopreservation: experimental or established and a cure for the menopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian volume correlates strongly with the number of nongrowing follicles in the human ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The infant and pubertal human ovary: Balbiani's body-associated VASA expression, immunohistochemical detection of apoptosis-related BCL2 and BAX proteins, and DNA fragmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Commuting the death sentence: how oocytes strive to survive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Germline energetics, aging, and female infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

21 January 2018

Telomerase in the ovary

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Production of offspring from a germline stem cell line derived from neonatal ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian follicle culture: advances and challenges for human and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Isolation, characterization and propagation of mitotically active germ cells from adult mouse and human ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma--evaluation by using antimüllerian hormone and retrieved oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Introduction: fertility preservation, from cancer to benign disease to social reasons: the challenge of the present decade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian transplantation between monozygotic twins discordant for premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovary cryopreservation and transplantation for fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Pregnancy after Transplantation of Cryopreserved Ovarian Tissue in a Patient with Ovarian Failure after Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Livebirth after orthotopic transplantation of cryopreserved ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Underuse of ovarian transposition in reproductive-aged cancer patients treated by primary or adjuvant pelvic irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Laparoscopic preservation of ovarian function: an underused procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian stimulation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

An OHSS-Free Clinic by segmentation of IVF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Storage of human oocytes in the vapor phase of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Oocyte cryopreservation for donor egg banking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

High survival rate of vitrified human oocytes results in clinical pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The efficacy and safety of human oocyte vitrification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Highly efficient vitrification method for cryopreservation of human oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Successful ongoing pregnancies after vitrification of oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Embryo culture: can we perform better than nature?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Luteal phase GnRHa trigger in random start fertility preservation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation in women of reproductive age with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Response to ovarian stimulation in patients facing gonadotoxic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Future Directions in Oncofertility and Fertility Preservation: A Report from the 2011 Oncofertility Consortium Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Preserving fertility in prepubertal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

IVF outcome in patients with orthotopically transplanted ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Cryopreservation and xenotransplantation of human ovarian tissue: an ultrastructural study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Effect of cryopreservation and transplantation on the expression of kit ligand and anti-Mullerian hormone in human ovarian tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Vitrification as an alternative means of cryopreserving ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

In vitro development of secondary follicles from cryopreserved rhesus macaque ovarian tissue after slow-rate freeze or vitrification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Morphological and functional preservation of pre-antral follicles after vitrification of macaque ovarian tissue in a closed system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Successful vitrification and autografting of baboon (Papio anubis) ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Immunohistochemical localization of growth factors after cryopreservation and 3 weeks' xenotransplantation of human ovarian tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

3D systems delivering VEGF to promote angiogenesis for tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Detection of Hodgkin lymphoma within ovarian tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Histologic evaluation of fresh human ovarian tissue before cryopreservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Trends in incidence rates of invasive lobular and ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Strategies to support human oocyte development in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Oocyte development in bovine primordial follicles is promoted by activin and FSH within a two-step serum-free culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Should we isolate human preantral follicles before or after cryopreservation of ovarian tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Vitrification and xenografting of human ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Germline stem cells and follicular renewal in the postnatal mammalian ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Offspring from Oocytes Derived from in Vitro Primordial Germ Cell-like Cells in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Natural history of the mammalian oocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Culture of oocytes and risk of imprinting defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

A review of 15 years of ovarian tissue bank activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian transposition before pelvic irradiation: indications and functional outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The Valencia Programme for Fertility Preservation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Safety of ovarian autotransplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian tissue banking in patients with Hodgkin's disease: is it safe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

[Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ovarian stem cells--potential roles in infertility treatment and fertility preservation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.205

Ageing-associated aberration in meiosis of oocytes from senescence-accelerated mice.

31 March 2020

1 reference

12 December 2020

The significance of local cellular immune response of women 50 years of age and younger with endometrial carcinoma.

1 reference

12 December 2020

Options for fertility preservation in pediatric populations undergoing cancer chemotherapy.

1 reference

12 December 2020

Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study

1 reference

12 December 2020

First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.205

1 reference

PubMed ID

24166000

Dimensions Publication ID

29 August 2017

1022673231

0 references

Fatcat ID

release_quuydtb4uzhvbcjfnp5ktpxln4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/quuydtb4uzhvbcjfnp5ktpxln4

24 November 2022

mapped directly with Wikidata item

PubMed ID

24166000

1 reference

PubMed ID

24166000